The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes

被引:84
作者
Noble, JA
Valdes, AM
Thomson, G
Erlich, HA
机构
[1] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA
[2] Roche Mol Syst, Dept Human Genet, Alameda, CA USA
[3] Childrens Hosp Oakland, Inst Res, Oakland, CA USA
关键词
D O I
10.2337/diabetes.49.1.121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
HLA-DPB1 genotypes were determined for samples from 269 multiplex Caucasian families from the Human Biological Data Interchange. DRB1 and DQB1 loci were also characterized, allowing assignment of DPB1 alleles to haplotypes and calculation of linkage disequilibrium values. Frequencies for several DPB1 alleles differed significantly between patients and affected family-based control subjects. Some differences were attributable to linkage disequilibrium with DR and DQ alleles, whereas others were not. DPB1*0301 and DPB1*0202 alleles are predisposing for type 1 diabetes in these data, not only in analyses of individual alleles, but also in genotype analyses. DPB1*0402 appears protective; however, stratification analysis indicates that its protective effect is specific for DR3 haplotypes. A protective role for DPB1*0401 is suggested by genotype analysis. For increased statistical power, DPB1 alleles were pooled into three categories: susceptible, neutral, and protective after removal of effects due to linkage disequilibrium with DR-DQ. Analysis of these pools suggests that DPB1 primarily affects susceptibility to, rather than protection from, type 1 diabetes in a dominant fashion. This effect is more apparent in patients with genotypes other than the highest risk DR3/DR4-DQB1*0302 genotype. These data support a role for the DPB1 locus in conferring susceptibility to type 1 diabetes.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 15 条
[1]   AN EMPIRICAL-INVESTIGATION OF SOME EFFECTS OF SPARSENESS IN CONTINGENCY-TABLES [J].
AGRESTI, A ;
YANG, MC .
COMPUTATIONAL STATISTICS & DATA ANALYSIS, 1987, 5 (01) :9-21
[2]  
Agresti A., 1990, Analysis of categorical data
[3]  
BALDUCCISILANO PL, 1995, J AUTOIMMUN, V8, P425, DOI 10.1006/jaut.1995.0034
[4]  
BLALOCK HM, 1979, SOCIAL STAT, P625
[5]   Nomenclature for factors of the HLA system, 1996 [J].
Bodmer, JG ;
Marsh, SGE ;
Albert, ED ;
Bodmer, WF ;
Bontrop, RE ;
Charron, D ;
Dupont, B ;
Erlich, HA ;
Fauchet, R ;
Mach, B ;
Mayr, WR ;
Parham, P ;
Sasazuki, T ;
Schreuder, GMT ;
Strominger, JL ;
Svejgaard, A ;
Terasaki, PI .
TISSUE ANTIGENS, 1997, 49 (03) :297-321
[6]  
BUGAWAN TL, 1990, IMMUNOGENETICS, V32, P231
[7]   A NEW METHOD TO TEST GENETIC MODELS IN HLA ASSOCIATED DISEASES - THE MASC METHOD [J].
CLERGETDARPOUX, F ;
BABRON, MC ;
PRUM, B ;
LATHROP, GM ;
DESCHAMPS, I ;
HORS, J .
ANNALS OF HUMAN GENETICS, 1988, 52 :247-258
[8]   HLA-DP VARIATION AS ADDITIONAL RISK FACTOR IN IDDM [J].
EASTEAL, S ;
KOHONENCORISH, MRJ ;
ZIMMET, P ;
SERJEANTSON, SW .
DIABETES, 1990, 39 (07) :855-857
[9]   Association of HLA-DPB1(*)0301 with IDDM in Mexican-Americans [J].
Erlich, HA ;
Rotter, JI ;
Chang, JD ;
Shaw, SJ ;
Raffel, LJ ;
Klitz, W ;
Bugawan, TL ;
Zeidler, A .
DIABETES, 1996, 45 (05) :610-614
[10]   HLA associations in insulin-dependent diabetes mellitus: No independent association to particular DP genes [J].
Lie, BA ;
Akselsen, HE ;
Joner, G ;
DahlJorgensen, K ;
Ronningen, KS ;
Thorsby, E ;
Undlien, DE .
HUMAN IMMUNOLOGY, 1997, 55 (02) :170-175